ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Gross margin 2022–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) gross margin by fiscal year — reported gross profit divided by reported revenue.
90.2%FY2025 · since FY2022: 79.5% → 90.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 90.2% | -0.0 pp |
| FY2024 | 90.3% | -1.4 pp |
| FY2023 | 91.6% | +12.1 pp |
| FY2022 | 79.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARQT financial trends
ARQT RevenueARQT Net incomeARQT Net marginARQT Gross profitARQT Operating incomeARQT Operating marginARQT Operating cash flowARQT Free cash flowARQT Capital expendituresARQT Return on equityARQT Stock buybacksARQT Dividends paidARQT Total assetsARQT Total liabilitiesARQT Shareholders’ equityARQT overview →